- Q3 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 08, 2024C$1.92 (-28.89%)Earnings
- Q2 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023C$2 (-2.44%)Earnings
- Medexus Pharmaceuticals Inc Annual Shareholders Meeting TranscriptSep 21, 2023
- Medexus Pharmaceuticals Inc at Openexchange Share Series (Virtual) TranscriptAug 14, 2023
- Q1 2024 Medexus Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023C$2.92 (-0.34%)Earnings
- Q4 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptJun 22, 2023C$1.4 (+12.90%)Earnings
- Medexus Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Q3 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 09, 2023C$1.8 (-1.10%)Earnings
- Q2 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022C$1.78 (-26.45%)Earnings
- Medexus Pharmaceuticals Inc Investor Update Call TranscriptSep 21, 2022
- Medexus Pharmaceuticals Inc Annual Shareholders Meeting TranscriptSep 15, 2022
- Q1 2023 Medexus Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022C$2.95 (+18.00%)Earnings
- Q4 2022 Medexus Pharmaceuticals Inc Earnings Call TranscriptJun 23, 2022C$1.95 (-9.30%)Earnings
- Medexus Pharmaceuticals Inc to Discuss Treosulfan Data TranscriptJun 06, 2022
- Q3 2022 Medexus Pharmaceuticals Inc Earnings Call TranscriptFeb 10, 2022C$3.27 (+5.48%)Earnings
- Medexus Pharmaceuticals Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 08, 2022
- Medexus Pharmaceuticals Inc at SNN Network Canada Virtual Event TranscriptDec 08, 2021
- Medexus Pharmaceuticals Inc at Benzinga Global Small Cap Conference (Virtual) TranscriptOct 28, 2021
- Medexus Pharmaceuticals Inc at SNN Network Summer Event (Virtual) TranscriptAug 19, 2021
Medexus Pharmaceuticals Inc Investor Update Call Transcript
Hello, everyone. This is Victoria Rutherford from Adelaide Capital. Thanks for joining us today. We're here with Ken d'Entremont and Marcel Konrad, CEO and CFO of Medexus Pharmaceuticals.
Before we begin, I would like to remind everyone that this discussion will include forward-looking information that is based on management's current information and assumptions and is subject to risks and uncertainties that could cause actual results to differ materially from historical or anticipated results.
This discussion may also reference non-IFRS financial measures or non-GAAP measures, including references to adjusted net loss and adjusted EBITDA. These measures do not have a standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other companies.
For more information about forward-looking information and non-GAAP measures and a reconciliation of adjusted net loss and adjusted EBITDA to net loss, refer to Medexus' most recent management discussion and analysis. Medexus' MD&A and other filings are available on the company's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)